John Cunningham Virus seroconversion during natalizumab treatment

John Cunningham Virus seroconversion during natalizumab treatment

Introduction: Multiple sclerosis is a progressive disease that is difficult to predict, originating in cases of disability. Natalizumab is a highly effective disease-modifying therapy but is associated with greater John Cunningham virus (JCV) reactivation and consequent increased risk of developing...

Full description

Saved in:
Bibliographic Details
Main Authors: Erica Freire de Vasconcelos-Pereira, Vanessa Marcon de Oliveira, Cristiane Munaretto Ferreira, Giovanna Arisa Tano de Paula, Maria Tereza Ferreira, Pedro Rippel Salgado, João Américo Domingos, Massaco Satomi, Fabiany Monteiro da Silva, Camila Yamanaka Akamine, Vanessa Terezinha Gubert
Format: Article
Language:English
Published: Faculdade de Medicina do ABC 2024-11-01
Series:ABCS Health Sciences
Subjects:
Multiple Sclerosis
Leukoencephalopathy, progressive multifocal
Natalizumab
JC Virus
Seroconversion
therapeutics
Online Access:https://www.portalnepas.org.br/abcshs/article/view/2430
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.portalnepas.org.br/abcshs/article/view/2430

Similar Items